Pistachio

Other Names

AlfóncigoAntepfıstığıEchte PistazieFisticulFıstıkFistiqFustaqFustuqGreen almondLentiscus vera (L.) KuntzeMantelipistaasiPestePestehPistaPistacchioPistachePistachierPistachier communPistachier cultivéPistachier vraiPistachio nutPistachio treePistachoPistacia badghysi K.P.PopovPistacia macrophylla Pers.Pistacia narbonnensis L.Pistacia narbonnensis var. bauhini Ten.Pistacia nemausensis Req.Pistacia nemausensis Req. ex Planch.Pistacia nigricans CrantzPistacia officinarum AitonPistacia reticulata Willd.Pistacia trifolia L.Pistacia variifolia Salisb.Pistacia veraPistacia vera f. semidehiscens K.P.PopovPistacia vera L.Pistacia vera var. trifolia (L.) Poir.Pistacja właściwaPistagPistakPistaschPistasjPistatxondoaPistaziePistazienbaumPisteqTerebinthus pistacia Dum.Cours.Фисташка настоящая

Synopsis

Pistachio (Pistacia vera L.): A Comprehensive Reference Article

1. Identity, Taxonomy, and Botanical Description

Pistacia vera L. is a small tree of the cashew family (Anacardiaceae) producing edible seeds, grown in dry lands in warm or temperate climates. It is the only species of the Pistacia genus that produces edible nuts. The tree's common name, "pistachio," applies both to the tree and to its commercially important seed kernel.

The pistachio tree has wide-spreading branches but rarely exceeds 9 metres (30 feet) in height. Each leaf has one to five pairs of thick, wide, leathery, pinnate leaflets. The tree is believed to be indigenous to Iran and is widely cultivated from Afghanistan to the Mediterranean region and in California.

The pistachio's unique green and purple kernel color is a result of its lutein and anthocyanin content. The phytonutrient content, principally catechins, lutein, zeaxanthin, anthocyanins and chlorophyll, are responsible for these characteristic colours.

Common Names and Regional Synonyms

The species is known as pistachio in English, pista or piste in Persian and Urdu, fıstık in Turkish, pistache in French and German, and pistacchio in Italian. In Iran, it is colloquially called the "smiling nut."

Common Forms and Preparations

Raw kernels: Unsalted, unroasted nuts consumed whole or used in cooking.
Dry-roasted or oil-roasted: Seed kernels can be eaten fresh or roasted and are commonly used in a variety of desserts, including baklava, halvah, and ice cream.
Pistachio paste and flour: Ground kernels used as an ingredient in confections and sauces.
Pistachio oil: Cold-pressed oil extracted from the kernels, used culinary and cosmetically.
Pistachio extract / dietary supplement capsules: Standardized extracts, including skin and kernel extracts, evaluated in research settings for antioxidant delivery.
The seeds are also used for yellowish-green colouring in confections.

2. Historical and Traditional Use

Origins and Prehistoric Consumption

Archaeological evidence shows that pistachio consumption was widespread in the Central Asian area as early as 6750 BC. The pistachio is one of the oldest and most valued species of dried fruit, with archaeological finds attesting to its presence as early as 6760 BC in the lands of present-day Jordan.

Ancient Persia and the Middle East

Ancient pistachio origins trace to Central Asia and the Middle East — specifically modern Iran, Afghanistan, and Turkey. Persian farmers cultivated Pistacia vera as early as 700 BCE, turning wild harvesting into organized orchard agriculture. At this time, pistachios were considered a luxury food and were reserved for royalty and the wealthy elite.

The Persians used the pistachio abundantly, not only for desserts but also in ground-up form to thicken and enhance sauces. Even the oil from the pistachio was pressed and used for cooking as well as for flavoring desserts. In biblical times, chopped pistachios were added to fruit compotes, puddings, and stuffings, while the nuts in their ground-up form added body and flavor to many savory sauces.

Spread to the Classical World

According to Pliny the Elder's Naturalis Historia, the pistachio tree was native to Syria and it was only thanks to the intervention of the consul Lucius Vitellius the Elder that it reached Italy and Spain. The nuts traveled from Syria to Italy in the first century AD and spread throughout the Mediterranean from there.

Arab, Islamic, and Medieval Traditions

The Arabs learned culinary secrets from the Persians and included pistachios in dessert delicacies such as baklava. Pistachios were willing travelers and held up well on distant journeys, trekking from Persia to China via the Silk Route. When the Arabs settled in southern Spain, known as Andalusia, and in Sicily during medieval times, they introduced many foods from their native lands.

In traditional Islamic medicine, the writings recorded in valid Persian medical references such as Al-Qanun Fi al-Tibb (Canon of Medicine) by Ibn-e Sina (980–1037 AD) include discussion of the Pistacia genus. Various industrial and traditional uses are mentioned for the main parts of wild pistachio (resin and fruit) including in foods and medicine, and recent research investigates wide pharmacological properties from various parts, such as antimicrobial, antioxidant, antidiabetic, antitumor, and antihyperlipidemic activities.

Traditional Medicinal Uses

Pistachios were highly valued in ancient civilizations such as the Greeks, Romans, and Egyptians. They were often used in medicines and were believed to have various health benefits. Traditional use included application as a diuretic to promote urination and reduce fluid retention in the body.

3. Key Constituents and Active Compounds

Macronutrient Profile

The pistachio is a nutrient-dense nut with a heart-healthy fatty-acid profile as well as protein, dietary fiber, potassium, magnesium, vitamin K, γ-tocopherol, and a number of phytochemicals. The seeds are high in protein, fat, dietary fiber, and vitamin B6.

Pistachios are rich in fat, protein, dietary fiber, trace elements (Fe, Zn, Cu, Mn) and minerals (Ca, P, K, Mg, Na). Lipids mainly consist of monounsaturated fatty acids (MUFA; approximately 33.8 g/100g), primarily oleic acid (approximately 32.4 g/100g); polyunsaturated fatty acids (PUFA) are mostly represented by linoleic acid (approximately 7.49 g/100g).

Comparison with Other Nuts

Among nuts, pistachios contain the highest levels of potassium, γ-tocopherol, vitamin K, phytosterols, and xanthophyll carotenoids. Compared with other nuts, pistachios have a lower fat and energy content, and higher levels of fiber (both soluble and insoluble), potassium, phytosterols, γ-tocopherol, vitamin K, and xanthophyll carotenoids.

Carotenoids

Lutein and zeaxanthin are two xanthophyllic compounds present in pistachios, responsible for the color and antioxidant activity. Pistachio is characterized by its carotenoid content, particularly lutein and zeaxanthin with an amount of about 2760 μg/100g and β-carotene of about 200 μg/100g. Compared with hazelnuts, pistachio exhibits 16-fold and eight-fold higher levels of lutein/zeaxanthin and β-carotene, respectively.

Carotenoids in pistachios include lutein, zeaxanthin, and β-carotene, as detected by HPLC assay. Raw pistachios have significantly higher contents of lutein and β-carotene when compared with roasted pistachio kernels, except for zeaxanthin. USDA values for roasted pistachios show lower carotenoid content, possibly due to the thermal sensitivity of these compounds.

Pistachios are the only nut that contains significant amounts of lutein and zeaxanthin.

Tocopherols (Vitamin E)

β- and γ-tocopherols are the major isomers of vitamin E in both raw and roasted pistachios, accounting for approximately 87–88% of the total vitamin E content. The α-tocopherol concentration of Kerman pistachios was reported at 5.34 mg per 100g, while the γ-tocopherol content was 39.71 mg per 100g.

Polyphenols and Flavonoids

Pistachios are a good source of protein, fiber, monounsaturated fatty acids, minerals and vitamins, as well as carotenoids, phenolic acids, flavonoids and anthocyanins. Polyphenols in pistachios are important contributors to the antioxidant and anti-inflammatory effect, as demonstrated in vitro and in vivo through animal studies and clinical trials.

Research using HPLC and related analytical methods has identified the dominant bioactive phenolic compounds in whole California pistachios. The dominant bioactives in whole pistachios include lutein [42.35 μg/g fresh weight], chlorophyll a (142.24 μg/g FW), γ-tocopherol (182.20 μg/g FW), flavan-3-ols (catechins) (199.18 μg/g FW), luteolin (217.89 μg/g FW), myricetin (135.18 μg/g FW), and cyanidin-3-galactose (38.34 μg/g FW).

Pistachio skins contain cyanidin-3-O-galactoside, gallic acid, catechin, and eriodictyol-7-O-rutinoside. Pistachio kernels contain quercetin-3-O-rutinoside, genistein, genistein-7-O-glucoside, and daidzein. Pistachios are the only nut containing anthocyanins in the skin.

Bronte-variety pistachios are a valuable source of bioactive compounds such as total polyphenols (501.5 mg/100g), lutein (1.26 mg/100g), β-carotene (0.18 mg/100g), γ-tocopherol (19.2 mg/100g), and phytosterols (134.4 mg/100g).

Phytosterols

Among phytosterols in pistachio, the main compound is β-sitosterol (accounting for 86% of total phytosterol content), followed by Δ5-avenasterol (6.3%). Among widely consumed nuts, pistachios hold the supreme concentrations of potassium, γ-tocopherol, phytosterols, and xanthophyll carotenoids.

Antioxidant Status

Pistachios have been listed among the 50 foods highest in antioxidant polyphenols. Antioxidant vitamins and a number of antioxidant polyphenols are present in both the hydrophilic and lipophilic nut extract, with total antioxidant activity measured by the TAA test being approximately 50-fold higher in the hydrophilic than in the lipophilic extract.

Bioaccessibility

Polyphenols, xanthophylls, and tocopherols from pistachios have been demonstrated to be rapidly accessible in the stomach, thus maximising the possibility of absorption in the upper small intestine.

4. Scientific Evidence by Health Area

4.1 Cardiovascular Health and Lipid Profile

Evidence strength: Moderate-to-good (multiple RCTs, systematic reviews, meta-analyses).

Five published randomized cardiovascular trials have shown that pistachios promote heart-healthy blood lipid profiles. A literature review identified eight relevant studies, and the results showed a consistent improvement in serum lipid profile across cholesterol fractions. With one exception, all studies reported a notable decrease in mean LDL-cholesterol ranging from 7.6 to 9.7% of baseline level. In four of seven studies that reported a change in HDL-cholesterol level, the mean HDL-cholesterol increased after the intervention.

Inclusion of pistachios in a healthy diet beneficially affects cardiovascular disease risk factors in a dose-dependent manner. In a dose-response study evaluating two doses of pistachios added to a lower-fat diet, including 1 or 2 servings per day of pistachios in a healthy diet reduced LDL cholesterol by 9% to 12%. The effects on the ratio of LDL cholesterol to HDL cholesterol were dose-dependent, with larger improvements at higher intakes.

In a randomized trial in adults with type 2 diabetes, total cholesterol and the ratio of total to HDL cholesterol were significantly lower following the pistachio diet compared to the control diet. Triglycerides were significantly lower (p=0.003) following the pistachio diet (1.56 mmol/L) compared to the control diet (1.84 mmol/L). There were no treatment differences in fasting glucose and insulin, but fructosamine was significantly lower (p=0.03) following the pistachio diet. The authors concluded that daily pistachio consumption can improve some cardiometabolic risk factors in adults with well-controlled type 2 diabetes, supporting recommendations that individuals with diabetes follow healthy dietary patterns including nuts.

A large dietary context is provided by the PREDIMED study. In February 2013, the landmark PREDIMED study published in the New England Journal of Medicine showed a Mediterranean diet supplemented with nuts significantly reduced cardiac events. In this clinical trial of approximately 7,400 subjects, those who ate a Mediterranean diet with either one ounce of nuts per day or one liter of olive oil per week had a 30% risk reduction in heart disease-related events. (Note: Pistachios were one component of the mixed nut intervention; their specific contribution cannot be isolated from this study.)

Preclinical data from animal studies support these findings. In rats fed a high-cholesterol diet, pistachio consumption significantly decreased triglycerides and markers of lipid peroxidation, and significantly increased total antioxidant activity. The authors concluded that pistachio supplementation may improve blood lipids and ameliorate oxidative stress in experimental hyperlipidemia.

4.2 Blood Pressure and Vascular Function

Evidence strength: Preliminary-to-moderate (limited RCTs).

Previous experimental studies have reported that pistachios can elicit a wide range of effects on lipid profile, blood pressure and inflammation. A systematic review and meta-analysis of randomised controlled trials specifically examined pistachio effects on blood pressure and vascular biomarkers, with published findings noting that emerging clinical evidence suggests that pistachios may help reduce oxidative and inflammatory stress and promote vascular health, glycemic control, appetite management, and weight control.

A study in adults with dyslipidemia found that diets containing pistachios reduced systolic blood pressure and peripheral vascular responses to stress. A related randomized trial also found that pistachio nut consumption modifies systemic hemodynamics, increases heart rate variability, and reduces ambulatory blood pressure in well-controlled type 2 diabetes. These effects are thought to relate to the favorable fatty acid profile, phytosterol content, and polyphenol-mediated endothelial benefits, though the precise mechanisms remain under investigation.

4.3 Glycemic Control and Type 2 Diabetes

Evidence strength: Moderate (multiple RCTs and meta-analyses), with some inconsistency in HbA1c outcomes.

A systematic review and meta-analysis evaluated the effects of pistachio nuts on glycemic control and insulin sensitivity in patients with type 2 diabetes mellitus, prediabetes, and metabolic syndrome. Six RCTs were included. Treatment with pistachio nuts exerted a significant reduction in fasting blood glucose (FBG) level (OR = 1.7, 95% CI 1.2–2.4, P = 0.002) and HOMA-IR index (OR = 1.5, 95% CI 1.0–2.4, P = 0.043), but no significant improvement was observed in hemoglobin A1c (HbA1c) level (OR = 1.4, 95% CI 0.9–2.1, P = 0.089) or fasting plasma insulin level. Pistachio nuts might cause a significant reduction in FBG and HOMA-IR, although HbA1c and fasting plasma insulin might not significantly improve in patients suffering from or at risk of type 2 diabetes.

Pistachio is a nut with high polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFA), polyphenols and carotenoids content, and the synergism between these compounds appears to affect glucose metabolism.

In a crossover study of women with gestational diabetes mellitus (GDM) or gestational impaired glucose tolerance, 42 g pistachios was compared to 100 g whole-wheat bread (WWB) as isocaloric test meals for postprandial glucose, insulin, and incretin responses. Isocaloric pistachio intake had minimal effect on blood glucose or insulin. In both gestational impaired glucose tolerance and GDM patients, significantly higher GLP-1 levels were observed at 90 and 120 minutes after pistachio compared to WWB intake. Significantly lower gastric inhibitory polypeptide (GIP) levels were also observed.

4.4 Body Weight and Satiety

Evidence strength: Mixed/preliminary (small RCTs, inconsistent findings).

Including nuts in the diet improves appetite control and does not lead to weight gain. However, for pistachios specifically, evidence from randomized intervention studies is limited and there are no robust data on the effect of pistachios on satiety. Four randomized, controlled clinical studies have evaluated the effect of including pistachios on body weight. A twelve-week weight-loss study in overweight or obese individuals who consumed either 53 g/d pistachios or 56 g/d of salted pretzels as an afternoon snack showed a significant reduction in BMI in the pistachio-supplemented group. This BMI reduction was greater than that in the pretzel group (24% vs. 22% reduction).

4.5 Gut Microbiota

Evidence strength: Emerging (animal studies and limited human trials).

In a mouse model, a pistachio diet significantly increased the abundance of healthy bacteria genera such as Parabacteroides, Dorea, Allobaculum, Turicibacter, Lactobacillus, and Anaeroplasma, and greatly reduced bacteria associated with inflammation, such as Oscillospira, Desulfovibrio, Coprobacillus, and Bilophila. Intake of pistachios also significantly decreased high-fat-diet-induced high levels of IL-1β and TNF-α in this model.

In a human randomized crossover trial in adults with prediabetes, intake of 57 g/d of pistachios as a nighttime snack altered stool microbial community diversity and composition compared with a carbohydrate-rich snack, providing evidence of stool microbial effects with pistachio consumption. Clustering of gut microbial communities after pistachio intake was driven by a greater abundance of Roseburia metagenome and Lachnospiraceae and a lower abundance of Flavonifractor, Eubacterium, Phascolarctobacterium, and Blautia genera. Limitations include the lack of dietary control, and higher fiber intake in the pistachio condition may also explain microbiota differences. Other bioactive components in pistachios (phenolic compounds) may also drive the microbial effects.

4.6 Anti-inflammatory and Antioxidant Activity

Evidence strength: Preliminary-to-moderate (in vitro, animal data, and some clinical data).

Polyphenols in pistachios are important contributors to the antioxidant and anti-inflammatory effect, as demonstrated in vitro and in vivo through animal studies and clinical trials. The inhibition of lipid oxidation has been demonstrated in preclinical models. The hydrophilic extract of pistachio inhibited dose-dependently both the metal-dependent and metal-independent lipid oxidation of bovine liver microsomes, and the Cu²⁺-induced oxidation of human low-density lipoprotein.

The rich composition in terms of phytochemicals, such as tocopherols, carotenoids, and, importantly, phenolic compounds, makes pistachio a powerful food to explore its involvement in the prevention of prevalent pathologies. Clinical anti-inflammatory effects specifically attributable to pistachio polyphenols in humans remain an area of active investigation; results from individual RCTs have been mixed on markers such as CRP and endothelial function.

4.7 Erectile Function

Evidence strength: Very preliminary (single small uncontrolled pilot study).

A prospective study investigated the effects of Antep pistachio on International Index of Erectile Function (IIEF) scores, penile color Doppler ultrasound parameters, and serum lipid levels in 17 married male patients with established erectile dysfunction. Patients were placed on a diet of 100 g pistachio nuts daily for 3 weeks. The mean IIEF-15 score improved from 36 ± 7.5 before the diet to 54.2 ± 4.9 after the diet (P=0.001). An increase in all five domains of IIEF was observed. Mean peak systolic velocity values improved significantly (P=0.018).

This study has significant methodological limitations. The main limitation is the lack of a control group, which makes it difficult to establish a causal relationship. The effect of pistachio on erectile dysfunction may be a placebo effect. The evidence base specifically examining pistachios and erectile dysfunction remains limited, with only a small number of studies directly investigating this relationship. The proposed mechanism links pistachio's arginine content (a precursor to nitric oxide) and its favorable effects on lipid profiles and vascular function to improved penile blood flow, but this requires confirmation in controlled trials.

4.8 Antimicrobial Activity

Evidence strength: In vitro only.

The antimicrobial and antiviral potential of pistachio polyphenols has been assessed and could help overcome drug resistance. In vitro research has identified anti-Candida activity from pistachio hull polyphenols. The highest antioxidant and anti-glycative activities were obtained for the Fandoghi (Fan1) cultivar. Potent inhibitory activity against Candida species was recorded with MIC values of 3.12–12.5 µg/mL. These findings have not yet been confirmed in clinical (human) studies.

5. Body Systems and Health Areas Associated with Pistachio Consumption

Cardiovascular system: Lipid modulation (LDL reduction, HDL improvement, triglyceride reduction), blood pressure reduction, vascular function improvement.
Metabolic/endocrine system: Glycemic control, reduction of insulin resistance (HOMA-IR), postprandial glucose attenuation.
Gastrointestinal system: Prebiotic-like modulation of gut microbiota, dietary fiber contribution to colonic fermentation.
Immune and inflammatory system: Reduction of pro-inflammatory cytokines (TNF-α, IL-1β) observed in animal models; emerging data in humans.
Ocular system: Pistachios are the only nut that contains significant amounts of lutein and zeaxanthin, carotenoids associated with macular pigment density and eye health, though direct clinical trials on pistachio consumption and ocular outcomes are lacking.
Reproductive/sexual health: Preliminary data suggest vascular-mediated benefits for erectile function; evidence is insufficient for clinical conclusions.
Weight management: Satiety promotion and BMI effects seen in some trials; evidence is mixed.

6. Dosages Reported in Clinical Studies

The following dosages have been specifically reported in published human clinical research:

56 g (approximately 1318 kJ) per day as an afternoon snack, administered for four weeks in a parallel-group RCT of healthy French women.
53 g/d consumed as an afternoon snack for 12 weeks in a weight-loss study in overweight or obese individuals.
57 g/d as a nighttime snack over 12 weeks in adults with prediabetes (microbiota crossover trial).
100 g pistachio nuts per day for 3 weeks in the erectile dysfunction pilot study.
42 g pistachios as a single acute test meal (crossover design) in the gestational diabetes glycemic response study.
In the dose-response cardiovascular study (Gebauer et al., Am J Clin Nutr 2008), two doses of pistachios were evaluated when added to a lower-fat diet for effects on lipids, lipoproteins, and apolipoprotein-defined lipoprotein subclasses. The reported doses tested were approximately 42 g/d (1 serving) and 85 g/d (2 servings).

Most studies used pistachios as a dietary food rather than a standardized pharmaceutical supplement. No established pharmacopeial dosage monograph currently exists for pistachio as a medicinal preparation.

7. Safety Considerations and Interactions

Allergy and IgE-Mediated Reactions

Pistachio (Pistacia vera) is widely consumed among tree nuts but is capable of triggering severe IgE-mediated reactions in allergic individuals. Among tree nuts, allergies to pistachios are common in those with cashew nut allergy, and multiple homologous allergenic components are shared between the two nuts. Five major allergens from pistachio have been identified: Pis v 1 (7 kDa), Pis v 2 (32 kDa), Pis v 3 (50 kDa), Pis v 4 (23 kDa), and Pis v 5 (36 kDa).

Pistachio and cashew show a high level of co-sensitization or cross-reactivity since they are genetically closely related nuts. The NUTCRACKER study, the IDEAL study, and a retrospective study conducted in France reported a high prevalence (75–98%) of pistachio sensitization in cashew-nut-sensitized children. In studies of tree nut-allergic individuals, allergy to cashew coincided in almost all assessed subjects with pistachio allergy.

Results indicate that exposure of people to pistachio significantly affects the prevalence of allergic reactions. Among pistachio-allergic subjects, such exposure may affect co-sensitivities with other nuts, including cashew and almond. The plant taxonomic classification of pistachio and other tree nuts does appear to predict allergenic cross-reactivity.

Aflatoxin Contamination

Pistachio fruit components, including hulls (mesocarps and epicarps), seed coats (testas), and kernels (seeds), all contribute to variable aflatoxin content in pistachios. Wounded kernels, with or without the seed coat, were readily colonized by Aspergillus flavus and after 10 days of incubation contained 37 times more aflatoxin than similarly treated unwounded kernels. Early-smiling pistachios are one of the most important sources of pistachio contamination with aflatoxin in garden and processing stages.

Delayed harvesting and processing and storage has been shown to significantly influence and often increase aflatoxin B1 contamination of pistachio nuts. Regulatory agencies including the EU and the US FDA apply maximum residue limits for aflatoxins in tree nuts; commercially processed and properly stored pistachios from reputable sources generally comply with these limits.

Energy Density and Caloric Contribution

Pistachio nuts are energy-dense. Multiple clinical studies (noted above) have examined whether adding pistachios to the diet leads to compensatory reductions in caloric intake elsewhere, with results generally showing that body weight does not increase significantly in controlled conditions. However, uncontrolled consumption in energy-replete individuals may contribute to positive energy balance.

Oxalate and Phytate Content

Pistachio phytic acid content has been quantified at approximately 1763 mg/100g, with additional inositol phosphate forms also detected. Phytic acid (phytate) can reduce the bioavailability of certain minerals (iron, zinc, calcium) through binding in the gastrointestinal tract, a consideration for individuals with marginal mineral status who consume very large quantities.

Drug Interactions

No specific pharmacokinetic drug interactions with pistachio constituents have been established in controlled human studies. The phytosterol content may modestly complement the lipid-lowering effects of statins through complementary mechanisms (dietary cholesterol reduction vs. HMG-CoA reductase inhibition), though this has not been formally studied for pistachios specifically. The high vitamin K content is a theoretical consideration for individuals on vitamin K antagonist anticoagulants (e.g., warfarin) if intake is substantially and suddenly changed, as consistent with general dietary guidance for all vitamin K-rich foods.

Absence of Serious Adverse Events in Trials

A pistachio diet improved erectile function parameters without any associated side effects in the Aldemir et al. pilot study. Across the larger body of cardiovascular and metabolic RCTs reviewed in the literature, no clinically significant adverse events attributable specifically to pistachio consumption have been reported in non-allergic individuals at the dosages studied.

References

Health Conditions

Health conditions that Pistachio may help support.

No conditions available.

Body Systems

Body systems that Pistachio may help support.

No body systems available.